This is a past event. Registration is closed. View other AustCham China events.
Join AustCham China for a webinar with Professor Sharon Lewin, Director, Peter Doherty Institute for Infection and Immunity to be held Thursday 20 February. The Doherty Institute in Melbourne were the first to grow and share the COVID-19 virus with the world. A eureka moment in the global race to develop a vaccine.
Tune in to hear Prof. Lewin provide insight on what is currently known about the virus, how is the current situation likely to develop and what has been learned from this outbreak which will influence how the next pandemic will be tackled.
Prof. Lewin will also be providing details on the Doherty Institute's success in being the first to grow the COVID-19 from a patient sample and what this means in terms of investigating, diagnosing and treating the virus globally.
In addition to this presentation, Tim White, Trade Commissioner and Commercial Consul, West China, Australian Trade and Investment Commission, Head of Austrade China's International Health team, will present a holistic overview of the impacts the COVID-19 virus will have on Australia's engagement with China in the medical sector.
Join using a web browser or WebEx app
Click here. If prompted, below are meeting details:
Meeting number (access code): is 574 927 016.
Join from a video system or application
Dial 574927016@austrade.webex.com
You can also dial 210.4.202.4 and enter your meeting number.
Join by phone
Tap to call in from a mobile device (attendees only)
+61-29037-0069 Australia Toll
Join using Microsoft Lync or Microsoft Skype for Business
Dial 574927016.austrade@lync.webex.com
Agenda
11
02
-
11
25
Prof. Lewin, Director, Peter Doherty Institute for Infection and Immunity
Professor Sharon Lewin AO, FRACP, PhD, FAHMS11
25
-
11
40
11
40
-
12
00
Q&A
Professor Sharon Lewin AO, FRACP, PhD, FAHMS•Tim WhiteProf. Lewin, Director, Peter Doherty Institute for Infection and Immunity
Speakers
Professor Sharon Lewin AO, FRACP, PhD, FAHMS
Director of Peter Doherty Institute for Infection and ImmunitySharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Professor of Medicine, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow, Melbourne, Australia. The Doherty Institute employs over 700 staff with the overall vision to improve health globally through discovery research and the prevention, treatment and cure of infectious diseases.
She is an infectious diseases physician and basic scientist. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. She has given over 100 major invited talk internationally on the topic of an HIV cure and has published over 250 papers. She is also the lead investigator for the Australian Partnership for Preparedness Planning on Infectious Disease Emergencies (APPRISE) – an NHMRC funded Centre for Research Excellence that involves over 20 organisations across Australia. She is a member of the council of the National Health and Medical Research Council of Australia, an elected member of the Governing Council of the International AIDS Society (IAS) representing the Asia Pacific region and co-chairs the IAS Global Advisory board for the Towards an HIV Cure initiative. She is a member of the scientific advisory board for the Agence National du Recherche de SIDA and the Vaccine Research Centre at the National Institutes for Health, Bethesda MD.
In 2014 she was named Melburnian of the Year and in 2015 awarded the Peter Will Medal from Research Australia. She was made an Officer of the Order of Australia in 2019.
Tim White, Trade Commissioner and Consul (Commercial), Austrade
Speakers
Tim White
Trade Commissioner and Commercial Consul, West China at Australian Trade and Investment CommissionTim manages the Austrade West China team, with responsibility for advancing Australia’s trade and investment relationships with China's fastest growing region - a market of 200 million people across Sichuan, Chongqing, Yunnan and Guizhou.
Tim also leads Austrade China’s International Health team, working to open new opportunities for Australian business in China’s vast and dynamic healthcare, life sciences and aged care markets.
Tim has extensive experience in international business engagement, trade and economic policy development and economic analysis. He has a deep understanding of the Chinese market and the opportunities on offer for Australian business. He has worked closely with a range of Chinese companies investing in Australia.
Tim previously served for over ten years with the Department of Foreign Affairs and Trade, including in Beijing, Shanghai and Canberra. He is fluent in Mandarin.
Q&A
Speakers
Professor Sharon Lewin AO, FRACP, PhD, FAHMS
Director of Peter Doherty Institute for Infection and ImmunitySharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Professor of Medicine, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow, Melbourne, Australia. The Doherty Institute employs over 700 staff with the overall vision to improve health globally through discovery research and the prevention, treatment and cure of infectious diseases.
She is an infectious diseases physician and basic scientist. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. She has given over 100 major invited talk internationally on the topic of an HIV cure and has published over 250 papers. She is also the lead investigator for the Australian Partnership for Preparedness Planning on Infectious Disease Emergencies (APPRISE) – an NHMRC funded Centre for Research Excellence that involves over 20 organisations across Australia. She is a member of the council of the National Health and Medical Research Council of Australia, an elected member of the Governing Council of the International AIDS Society (IAS) representing the Asia Pacific region and co-chairs the IAS Global Advisory board for the Towards an HIV Cure initiative. She is a member of the scientific advisory board for the Agence National du Recherche de SIDA and the Vaccine Research Centre at the National Institutes for Health, Bethesda MD.
In 2014 she was named Melburnian of the Year and in 2015 awarded the Peter Will Medal from Research Australia. She was made an Officer of the Order of Australia in 2019.
Tim White
Trade Commissioner and Commercial Consul, West China at Australian Trade and Investment CommissionTim manages the Austrade West China team, with responsibility for advancing Australia’s trade and investment relationships with China's fastest growing region - a market of 200 million people across Sichuan, Chongqing, Yunnan and Guizhou.
Tim also leads Austrade China’s International Health team, working to open new opportunities for Australian business in China’s vast and dynamic healthcare, life sciences and aged care markets.
Tim has extensive experience in international business engagement, trade and economic policy development and economic analysis. He has a deep understanding of the Chinese market and the opportunities on offer for Australian business. He has worked closely with a range of Chinese companies investing in Australia.
Tim previously served for over ten years with the Department of Foreign Affairs and Trade, including in Beijing, Shanghai and Canberra. He is fluent in Mandarin.
Speakers
Professor Sharon Lewin AO, FRACP, PhD, FAHMS
Director of Peter Doherty Institute for Infection and Immunity
More Information
Tim White
Trade Commissioner and Commercial Consul, West China at Australian Trade and Investment Commission
More Information
Professor Sharon
Lewin AO, FRACP, PhD, FAHMS
Director of Peter Doherty Institute for Infection and Immunity
Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Professor of Medicine, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow, Melbourne, Australia. The Doherty Institute employs over 700 staff with the overall vision to improve health globally through discovery research and the prevention, treatment and cure of infectious diseases.
She is an infectious diseases physician and basic scientist. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. She has given over 100 major invited talk internationally on the topic of an HIV cure and has published over 250 papers. She is also the lead investigator for the Australian Partnership for Preparedness Planning on Infectious Disease Emergencies (APPRISE) – an NHMRC funded Centre for Research Excellence that involves over 20 organisations across Australia. She is a member of the council of the National Health and Medical Research Council of Australia, an elected member of the Governing Council of the International AIDS Society (IAS) representing the Asia Pacific region and co-chairs the IAS Global Advisory board for the Towards an HIV Cure initiative. She is a member of the scientific advisory board for the Agence National du Recherche de SIDA and the Vaccine Research Centre at the National Institutes for Health, Bethesda MD.
In 2014 she was named Melburnian of the Year and in 2015 awarded the Peter Will Medal from Research Australia. She was made an Officer of the Order of Australia in 2019.
Tim White
Trade Commissioner and Commercial Consul, West China at Australian Trade and Investment Commission
Tim manages the Austrade West China team, with responsibility for advancing Australia’s trade and investment relationships with China's fastest growing region - a market of 200 million people across Sichuan, Chongqing, Yunnan and Guizhou.
Tim also leads Austrade China’s International Health team, working to open new opportunities for Australian business in China’s vast and dynamic healthcare, life sciences and aged care markets.
Tim has extensive experience in international business engagement, trade and economic policy development and economic analysis. He has a deep understanding of the Chinese market and the opportunities on offer for Australian business. He has worked closely with a range of Chinese companies investing in Australia.
Tim previously served for over ten years with the Department of Foreign Affairs and Trade, including in Beijing, Shanghai and Canberra. He is fluent in Mandarin.
